keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GIP (3-42), human acetate is an antagonist of a glucose-dependent insulinotropic polypeptide (GIP) receptor and regulates insulin secretion and GIP metabolism in vivo.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | Inquiry | $ 227.00 | |
5 mg | Inquiry | $ 677.00 | |
10 mg | Inquiry | $ 1,085.00 | |
25 mg | Inquiry | $ 1,953.00 | |
50 mg | Inquiry | $ 2,929.00 |
Description | GIP (3-42), human acetate is an antagonist of a glucose-dependent insulinotropic polypeptide (GIP) receptor and regulates insulin secretion and GIP metabolism in vivo. |
In vitro | Dipeptidyl peptidase IV rapidly degrades the incretin hormone GIP in the circulation to form the N-terminally truncated peptide GIP(3-42) [1]. |
Synonyms | GIP (3-42), human acetate(1802086-25-4 Free base) |
Molecular Weight | N/A |
keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GIP (3-42), human acetate Tyrosine Kinase/Adaptors IGF-1R GIP (342), human acetate GIP (3 42), human acetate GIP , human acetate(1802086-25-4 Free base) GIP (3-42), human acetate(1802086-25-4 Free base) GIP , human Acetate inhibitor inhibit